October 2019

Allievex Corporation Enters Licensing Agreement With BioMarin Pharmaceutical

United States - Massachusetts

Faegre Drinker represented Allievex Corporation, a biopharmaceutical company based in Boston, Massachusetts, in connection with the in-licensing from BioMarin Pharmaceutical Inc. of exclusive worldwide rights to develop and commercialize an enzyme replacement therapy to treat mucopolysaccharidosis type IIIB (MPS IIIB), a rare pediatric neurodegenerative disease.

Related Legal Services